Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the clinical implications of new diagnostic tools in choosing when to initiate HCV therapy
- Recount clinical trial data from studies evaluating the management of difficult-to-treat patient cohorts with chronic hepatitis C
- Describe the clinical implications of new therapies on the management of patients with chronic hepatitis C
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.